Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

New biologicals with anticancer potential discovered in Belgium

May 4, 2012

Genentech ADC shows potential in prostate cancer models

May 4, 2012

Altor BioScience product to enter clinical testing for melanoma

May 3, 2012

BioAnalytica discloses novel HSP 90-targeting antibodies

May 3, 2012

Novel candidate cancer immunotherapies presented by Oxford BioTherapeutics

May 3, 2012

Amgen gives update on Xgeva sBLA

April 27, 2012

GlaxoSmithKline files application in Japan for ofatumumab

April 27, 2012

New Roche oncolytic targets chondroitin sulfate proteoglycan 4

April 25, 2012

Advaxis describes two new cancer immunotherapies

April 20, 2012

Melanoma trial of SCIB-1 clear to advance to phase II

April 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...